SCHEMBL6735308

SCHEMBL6735308

NCc1cccc(Oc2ccccc2OCc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.54
HTR1A P08908 2/20 0.49
ABCB1 P08183 1/20 0.49
DRD2 P14416 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CFD P00746 1/20 0.48
PLG P00747 1/20 0.48
PLAU P00749 1/20 0.48
F11 P03951 1/20 0.48
KLKB1 P03952 1/20 0.48
F7 P08709 1/20 0.48
TPSB2 P20231 1/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6734743 0.84 MAOB (0.71) MAOBHTR1AABCB1DRD2MAPT
SCHEMBL30207536 0.83 MAOB (0.70) MAOBMAPTL3MBTL1CYP4F2CYP4A11
SCHEMBL538599 0.83 MAOB (0.70) MAOBMAPTL3MBTL1CYP4F2CYP4A11
Hydrochloric Acid SCHEMBL538603 0.82 MAOB (0.73) MAOBCYP4F2CYP4A11BCHE
SCHEMBL921026 0.81 ALDH1A1 (0.53) MAOBABCB1MAPK1L3MBTL1
SCHEMBL1301847 0.79 LOXL2 (0.58) MAOBTDP1LOXL2LOXLTA4H
SCHEMBL5205314 0.79 GAA (0.60) MAOBMAPTLOXL2LOXDPP4
SCHEMBL30821651 0.78 MAOB (0.58) MAOBMAPTMAPK1TDP1L3MBTL1
SCHEMBL6726244 0.78 MAOB (0.58) MAOBMAPTMAPK1TDP1L3MBTL1
Hydrochloric Acid SCHEMBL919885 0.78 LOXL2 (0.57) MAOBTDP1LOXL2LOXLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800651-B2 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-10-05 US disclosed
US-20040006114-A1 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-01-08 US disclosed
EP-1255735-A2 PYRIDINE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2002-11-13 EP disclosed
WO-2001056990-A2 PYRIDINE DERIVATES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006114-A1 Potentiators of glutamate receptors GRM1, GRIN1, GRM2 MAOB 2349/4885HTR1A 367/4885ABCB1 1471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.